Next, PBMC from age and gender-matched healthy controls and patients with metastatic melanoma (Table S1 on-line) were stimulated with 6,000 IU/ml IL-2 for 24 hours followed by pSTAT5 phosphoflow staining. This evidence concerns the gene IL2 and metastatic melanoma.